Literature DB >> 28568844

Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations.

Nicolas Chéron1,2, Eugene I Shakhnovich1.   

Abstract

The BACE-1 enzyme is a prime target to find a cure to Alzheimer's disease. In this article, we used the MM-PBSA approach to compute the binding free energies of 46 reported ligands to this enzyme. After showing that the most probable protonation state of the catalytic dyad is mono-protonated (on ASP32), we performed a thorough analysis of the parameters influencing the sampling of the conformational space (in total, more than 35 μs of simulations were performed). We show that ten simulations of 2 ns gives better results than one of 50 ns. We also investigated the influence of the protein force field, the water model, the periodic boundary conditions artifacts (box size), as well as the ionic strength. Amber03 with TIP3P, a minimal distance of 1.0 nm between the protein and the box edges and a ionic strength of I = 0.2 M provides the optimal correlation with experiments. Overall, when using these parameters, a Pearson correlation coefficient of R = 0.84 (R2  = 0.71) is obtained for the 46 ligands, spanning eight orders of magnitude of Kd (from 0.017 nm to 2000 μM, i.e., from -14.7 to -3.7 kcal/mol), with a ligand size from 22 to 136 atoms (from 138 to 937 g/mol). After a two-parameter fit of the binding affinities for 12 of the ligands, an error of RMSD = 1.7 kcal/mol was obtained for the remaining ligands.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  MM-PBSA; drug design; free energy; molecular dynamics; protein-ligand interaction

Mesh:

Substances:

Year:  2017        PMID: 28568844     DOI: 10.1002/jcc.24839

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  5 in total

1.  Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.

Authors:  Mei Qian Yau; Abigail L Emtage; Nathaniel J Y Chan; Stephen W Doughty; Jason S E Loo
Journal:  J Comput Aided Mol Des       Date:  2019-04-15       Impact factor: 3.686

2.  Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies.

Authors:  Vladimir P Berishvili; Alexander N Kuimov; Andrew E Voronkov; Eugene V Radchenko; Pradeep Kumar; Yahya E Choonara; Viness Pillay; Ahmed Kamal; Vladimir A Palyulin
Journal:  Molecules       Date:  2020-07-11       Impact factor: 4.411

3.  Identification of potential interleukin-8 inhibitors acting on the interactive site between chemokine and CXCR2 receptor: A computational approach.

Authors:  Thi-Thuy-Nga Tran; Que-Huong Tran; Quoc-Thai Nguyen; Minh-Tri Le; Dieu-Thuong Thi Trinh; Khac-Minh Thai
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

4.  Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification.

Authors:  Yangfang Yun; Hengyi Song; Yin Ji; Da Huo; Feng Han; Fei Li; Nan Jiang
Journal:  J Biomed Res       Date:  2020-08-31

5.  Development of antibacterial compounds that constrain evolutionary pathways to resistance.

Authors:  Yanmin Zhang; Sourav Chowdhury; João V Rodrigues; Eugene Shakhnovich
Journal:  Elife       Date:  2021-07-19       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.